ReviewPharmacogenomics and personalized medicine2014

Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways.

Sarah R Hosford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.